Enanta Pharmaceuticals Inc (ENTA)
Net Receivables
$6.53M
Quarterly · Period ending: · USD
ENTA Net Receivables
Latest reported$6.53Mperiod ending
Latest reported$6.53Mperiod ending
ENTA Quarterly Net Receivables ($261.00K → $6.53M)
Quarterly net receivables
High-resolution chart · PNG
ENTA net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 6,534,000 | |
| 7,828,000 | |
| 8,493,000 | |
| 6,882,000 | |
| 8,356,999 | |
| 40,628,000 | |
| 40,162,000 | |
| 38,645,000 | |
| 40,631,000 | |
| 39,787,000 | |
| 39,907,000 | |
| 39,618,000 | |
| 18,892,000 | |
| 17,795,000 | |
| 51,288,000 | |
| 49,036,000 | |
| 48,207,000 | |
| 47,464,000 | |
| 56,399,000 | |
| 60,831,000 | |
| 52,194,000 | |
| 20,132,000 | |
| 31,743,000 | |
| 23,492,000 | |
| 18,653,000 | |
| 27,619,000 | |
| 52,570,000 | |
| 51,313,000 | |
| 44,367,000 | |
| 39,631,000 | |
| 69,886,000 | |
| 67,205,000 | |
| 57,262,000 | |
| 44,049,000 | |
| 23,109,000 | |
| 10,614,000 | |
| 7,511,000 | |
| 8,959,000 | |
| 10,417,000 | |
| 12,841,000 | |
| 13,978,000 | |
| 13,004,000 | |
| 18,878,000 | |
| 15,722,000 | |
| 13,100,000 | |
| 8,631,000 | |
| 78,508,000 | |
| 4,494,000 | |
| 2,658,000 | |
| 2,602,000 | |
| 1,208,000 | |
| 1,592,000 | |
| 1,857,000 | |
| 1,437,000 | |
| 14,876,000 | |
| 2,942,000 | |
| 3,489,000 | |
| 261,000 |